T ransfusion-related acute lung injury (TRALI) has recently become the most important cause of transfusion-related morbidity and mortality in the United States (1, 2) . Transfusion of higher plasma volume components, fresh frozen plasma (FFP) and platelets from leukocyte-alloimmunized donors, has been implicated as an important mechanism for severe TRALI reactions (1, (3) (4) (5) (6) (7) (8) . The evidence supporting the antibody hypothesis comes from several experimental models (6 -8) , case series (5) , and a small randomized study by Palfi et al. (9) in which transfusion of FFP from multiparous female donors, as opposed to nontransfused male donors, led to a small but significant reduction in arterial oxygenation and increase in inflammatory mediators in recipients. The American Association of Blood Banks (AABB) working group on TRALI recently recommended rapid implementation of strategies to minimize transfusion of high plasma volume components, FFP and apheresis platelets, from donors who may have antibodies toward recipients' white blood cells (10) . One of the recommended strategies includes transfusion of male-only donor plasma, as has been done in United Kingdom over the past 2 yrs (11) . While preliminary findings suggest a decrease of TRALI reported to the blood banks in the United Kingdom (11) , the effects on gas exchange, morbidity, and mortality in transfused critically ill patients have not been explored.
Since the transfusion of male-only products in our hospital could not be influenced by either the bedside provider or the blood bank staff, but rather by chance alone (thus eliminating indication bias), we reasoned that a large sample of transfused critically ill patients may be an appropriate setting for this observational study.
MATERIALS AND METHODS
From a database of transfused critically ill patients, we identified consecutive patients admitted to the four intensive care units (one medical, two surgical, and one mixed) who received Ͼ2 units of FFP or apheresis platelets Objective: To reduce the incidence of transfusion-related acute lung injury (ALI), the American Association of Blood Banks recently recommended rapid implementation of strategies to minimize transfusion of high plasma volume components, fresh frozen plasma and apheresis platelets, from potentially alloimmunized donors, especially females. The objective of this study was to evaluate the effect of transfusing components from male-only vs. female donors on development of ALI, gas exchange, and outcome in critically ill patients.
Design: In this retrospective case-control study, we identified patients who received high plasma volume components from maleonly donors and compared them with patients matched by severity of illness, postoperative state, and number of transfusions but who received high plasma volume components from female donors.
Setting: Four intensive care units at a tertiary medical center. Patients: Critically ill patients who received >2 units of fresh frozen plasma or apheresis platelets.
Interventions: None. Measurements and Main Results: From a database of 3,567 patients who received a total of 46,101 units of fresh frozen plasma and 6,251 units of apheresis platelets, we identified 112 patients who received three or more male-only donor components and 112 matched controls. Baseline characteristics, ALI risk factors, and development of ALI were similar between the two groups. Arterial oxygenation (PaO 2 /FIO 2 ) worsened after the female (mean difference ؊52, 95% confidence interval ؊14 to ؊91, p ‫؍‬ .008) but not after male-only donor product transfusion (mean difference 22, 95% confidence interval ؊23 to 67, p ‫؍‬ .325). Male-only component recipients had more ventilator-free days (median 28 vs. 27, p ‫؍‬ .006) and a trend toward lower hospital mortality rates (14% vs. 24%, p ‫؍‬ .054).
Conclusions: In critically ill recipients of high plasma volume components, gas exchange worsened significantly after transfusion of female but not male donor components. Prospective studies are needed to evaluate the effect of recommendations by the American Association of Blood Banks on outcome of transfused critically ill patients. (Crit Care Med 2007; 35:1645-1648)
KEY WORDS: platelet transfusion; fresh frozen plasma; adult; respiratory distress; adult; prevention; cohort study; outcome over a 6-yr period (1999 -2005) . We excluded patients who refused research authorization. We identified patients who received high plasma volume components from male-only donors (cases) and compared them with patients matched by severity of illness, postoperative state, and number of transfusions who had received three or more female-donor components with or without additional male components (controls). The Institutional Review Board approved the study protocol.
The main outcomes of interest were 1) the development of acute lung injury (ALI) defined according to the American European Consensus Conference (12) and posttransfusion hypoxemia, measured as PaO 2 /FIO 2 ratio; 2) hospital mortality; and 3) duration of mechanical ventilation estimated as 28-day ventilator-free days (13) .
The characteristics of the intensive care units (ICUs) and the Acute Physiology and Chronic Health Evaluation III database have been previously described (14) . Of the four ICUs, one was medical, two were surgical (thoracic/ vascular and general surgery/trauma), and one was mixed medical-surgical (14) . Demographic information, admission diagnosis, length of hospital and ICU stay, duration of mechanical ventilation, past medical history, and physiologic and laboratory variables were entered into the institutional Acute Physiology and Chronic Health Evaluation III database by the bedside ICU nurses in the same manner throughout the study period. The institutional transfusion database maintains data on type of blood product and time of transfusion as well as donor ID, gender, and age.
The presence or absence of hypoxemia, pulmonary edema, and ALI as well as underlying ALI risk factors were ascertained by co-investigators blinded to the specific transfusion characteristics. The co-investigators independently reviewed electronic medical records, including qualifying chest radiographs, arterial blood gases, and data from noninvasive and invasive hemodynamic monitoring. Sepsis was defined according to standard criteria (15) . Aspiration was defined as witnessed or strongly suspected aspiration of gastric contents into the airways. High plasma volume was defined as receiving Ͼ500 mL plasma volume (Ͼ2 units of FFP or apheresis platelets). Arterial blood gas analysis was done at the providers' discretion. We recorded posttransfusion arterial blood gas during the 24 hrs after the transfusion episode.
Statistical Analysis. Patients who received female plasma products were matched by severity of illness (ICU admission Acute Physiology and Chronic Health Evaluation III score Ϯ10), postoperative state, and exact number of high plasma volume components transfused. Cases and controls were compared using paired Student's t-test, Wilcoxon's signed rank test, and McNemar test as appropriate. JMP statistical software (JMP version 6.0, SAS Institute, Cary, NC) was used for all data analyses.
RESULTS
From a database of 3,567 patients who received total of 46,101 units of FFP and 6,251 units of apheresis platelets, we identified 112 patients who received three or more male-only donor components and 112 matched controls who received three or more female components.
There were no differences between cases and controls in baseline characteristics and ALI risk factors (Table 1 ). Recipients of male-only donor components tended to have less preexisting pulmonary edema and more renal replacement therapy ( Table 1) .
The rate of ALI after transfusion was similar between the two groups ( Table 2) . Male-only component recipients had more ventilator-free days (median 28 vs. 27, p ϭ .006) and a trend toward lower hospital mortality (14% vs. 24%, p ϭ .054, Table 2 ). In 49 matched pairs in whom arterial blood gas was obtained both before and after the transfusion, the PaO 2 /FIO 2 worsened significantly after the female (mean difference Ϫ52, 95% con-fidence interval Ϫ14 to Ϫ91, p ϭ .008) but not after male-only donor product transfusion (mean difference 22, 95% confidence interval Ϫ23 to 67, p ϭ .325). The difference between pre-and posttransfusion oxygenation (⌬PaO 2 /FIO 2 ) in matched pair analysis was statistically different between the two groups (p ϭ .016). Of note, hydrostatic pulmonary edema (transfusion-associated circulatory overload) occurred with similar frequency after both female and male donor plasma transfusion ( Table 2) . When patients who developed hydrostatic pulmonary edema were excluded from the analysis, PaO 2 / FIO 2 worsened significantly after female (Ϫ47, p ϭ .039) but not after male donor transfusion (Ϫ3.3, p ϭ .452).
The indications for transfusion included active bleeding (35%), invasive procedure (35%), postoperative anemia (16%), severe thrombocytopenia (4%), plasma exchange (1%), and other (9%). Twenty-five percent of patients received the transfusion outside practice guidelines.
DISCUSSION
In this retrospective case-control study, critically ill recipients of male-only donor plasma products had better oxygenation and more ventilator-free days but no significant difference in development of ALI after transfusion.
Randomized trials in critically ill patients have suggested a causal link between transfusion and the development of pulmonary complications, both hydrostatic pulmonary edema and ALI (16, 17) . High plasma volume components, rather than packed red blood cells, appear to be the most important implicated units (17, 18) . Previous case series have reported an association between high plasma volume components from potentially alloimmunized donors and the development of clinical TRALI (5, 19, 20) . We did not observe a significant difference in development of ALI. However, the small but significant differences in posttransfusion hypoxemia are similar to the findings from a small randomized trial by Palfi et al (9) . The increase in ventilator-free days is intriguing and deserves further study. It is certainly possible that the uncommon occurrence of fullblown TRALI reactions represents just a small proportion of posttransfusion pulmonary complications, particularly in critically ill patients (3, 21) . We can only speculate that the observed differences in oxygenation may have contributed to a decreased risk-adjusted morbidity and mortality for patients who received male-only high plasma volume components. The trend toward more preexisting pulmonary edema in recipients of female-donor components (Table 1 ) could in part explain the observed benefit on ventilator-free days; it does not explain the difference in posttransfusion hypoxemia between the two groups.
If our findings were confirmed after the implementation of a new AABB intervention (limiting the use of potentially alloimmunized donor plasma in production of FFP and apheresis platelets), the implications of the intervention in critically ill patients could be greater than envisioned by its proponents (10) . The proposed intervention is costly and may lead to shortage of apheresis platelets but should not affect the supply of FFP (4) . Prospective studies are needed to fully evaluate the impact of the proposed intervention not only on outcome of critically ill patients but also on availability and cost of blood products (4) .
Of note, 25% of patients in this study received the transfusion outside current practice guidelines (22) . A restrictive transfusion policy and adherence to appropriate indications are effective strategies to limit unnecessary exposure to blood products and transfusion complications. While significant progress have been made in avoiding unnecessary red cell transfusions, platelet and, in particular, FFP transfusions are commonly overused in North American hospitals (22) . The evidence base for prophylactic use FFP and platelet transfusions is also very limited, highlighting the need for clinical trials comparing conservative vs. liberal use of these blood products (22) .
Significant limitations of our study stem from its observational retrospective design. The differences in measured and unmeasured prognostic factors may decrease the confidence in the observed findings and limit causal inference. However, the absence of indication bias allowed our results to more closely approximate experimental conditions than is usually possible in observational studies. Additional limitations include the absence of female donor parity data and the discrete imbalance in pretransfusion PaO 2 /FIO 2 . The observed ⌬PaO 2 /FIO 2 (difference in pretransfusion and posttransfusion PaO 2 /FIO 2 ) as opposed to simple comparison of posttransfusion PaO 2 /FIO 2 ratio may be less likely to have been influenced by the baseline condition.
CONCLUSIONS
This retrospective case-control study shows that critically ill recipients of high plasma volume components from maleonly donors had less impairment of gas exchange and a higher number of ventilator-free days. Prospective studies are needed to evaluate the effects of AABB recommendations not only on the incidence of TRALI reported to blood centers but also on morbidity and mortality of transfused critically ill patients. 
